Source: MarketScreener

Constellation: Constellation Pharmaceuticals : Completion of Acquisition or Disposition of Assets (Form 8-K)

(marketscreener.com) Completion of Acquisition or Disposition of Assets. As previously disclosed, on June 2, 2021, Constellation Pharmaceuticals, Inc., a Delaware corporation , entered into an Agreement and Plan of Merger with MorphoSys AG, a German stock...https://www.marketscreener.com/quote/stock/CONSTELLATION-PHARMACEUTI-44979177/news/Constellation-Pharmaceuticals-nbsp-Completion-of-Acquisition-or-Disposition-of-Assets-Form-8-K-35869598/?utm_medium=RSS&utm_content=20210715

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Jigar Raythatha's photo - President & CEO of Constellation

President & CEO

Jigar Raythatha

CEO Approval Rating

98/100

Read more